Navigation Links
Dr. Chad Levitt Joins North Georgia Radiation Oncology Center
Date:9/10/2008

Radiotherapy Clinics of Georgia is proud to announce Dr. Chad Levitt, a Board Certified Radiation Oncologist has joined North Georgia Radiation Oncology Center, RCOG's Cumming, GA. Dr. Levitt specializes in head & neck, breast, GI, GYN, lung, prostate and other cancers.

Atlanta, GA. (PRWEB) September 10, 2008 -- Board Certified Radiation Oncologist Dr. Chad Levitt, has joined the North Georgia Radiation Oncology Center, Radiotherapy Clinics of Georgia's Cumming facility located on Haw Creek Parkway. No stranger to the Forsyth County area having lived most of his life in Flowery Branch, Dr. Levitt and his wife Alisha have moved back 'home.'

Prior to joining RCOG, Dr. Levitt was in private practice in Denver, Colorado, and then at a private practice cancer center in Melbourne, Florida.

Dr. Levitt received his doctorate of medicine from the Emory University School of Medicine, completed an internship in internal medicine at Exempla St. Joseph's Hospital in Denver, had IMRT training at the Emory School of Medicine and completed his residency in radiation oncology also at Emory.

Dr. Levitt is a member of a number of medical professional organizations and has chaired the Technologic Advisory Committee at RMCC. He has special interests in utilizing technology to improve patient education as well as treatment precision.

Dr. Levitt is proficient in SBRT/IGRT, Linac-based stereotactic radiosurgery, Cyberknife radiosurgery, CT/Flouro based and PET-CT based treatment planning, and has extensive brachytherapy experience in a number of areas. He specializes in head & neck, breast, GI, GYN, lung, prostate and other cancers.

The North Georgia Radiation Oncology Center is one of seven treatment facilities located in metropolitan Atlanta area and is part of Radiotherapy Clinics of Georgia's network of cancer treatment clinics. On staff at each clinic to assis
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. New Associate Joins Brinks Hofer Gilson & Lione in Salt Lake City
2. Ira Magaziner Joins Leaders in Peace Psychology at MSPP to Explore Ways to Transform Violence, Heal Families, Communities and World
3. Sharon Callahan Joins Diversified Agency Services Unit of Omnicom Group
4. Julia Roberts Joins Dave Matthews Band at Madison Square Garden in Stand Up For A Cure 2008 Concert Series
5. SIRIUS XM Radio Joins Stand Up To Cancer Campaign with Live Broadcast of Star-Studded Just Stand Up Fundraising Event on September 5
6. Master Permanent Make-up Artist and Educator Sulema Trevino Joins Nouveau Cosmetique Team
7. Dale Magner Joins Guardian as Vice President
8. Amy Street, Certified Prosthetist and Orthotist, Joins BridgePoint Medical Partner, Charlotte Orthotic and Prosthetic Center (COPC)
9. Senator Gordon Smith Joins Virginia Garcia Memorial Health Center and Pfizer to Honor a Community Caregiver
10. Hockert Joins Wausau Signature Agency
11. Alzheimers Association Joins Celebra Hispanic Health Education Campaign to Build Awareness About Impact of Alzheimers and Resources Available for Latinos

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2009)... recognize signs of depression , , SATUR... the holiday season can trigger melancholy as they... issues or worry about money problems, according t...ercome the seasonal blues, the AGS Foundation for ...et out and socialize or invite family and friends ...
(Date:11/27/2009)...swire-FirstCall/ -- The Gymboree Corporation (Nasd... will present at the NASDAQ OMX 23rd Investor Prog...ondon, England, on Wednesday, December 2, 2009, at...st of The Gymboree Corporation,s presentation over...click on "Our Company" at the bottom of the page, ...
(Date:11/27/2009)...hicles may reduce future disease burden, researche...ws) -- Encouraging city dwellers to walk and bicyc...public health benefits than increased used of low-..., The study compared the projected health effects...rios for London, England, and Delhi, India: busin...
(Date:11/27/2009)...ufacturers who use medical load cells at the heart...by bringing in technology partner Flintec early in...ive medical manufacturers are calling in Flintec l...jects, ensuring that progress will not be constrai...tdated technology. , (PRW...
(Date:11/26/2009)...molybdate (TM) has been shown in studies to be eff...se caused by an overload of copper, and certain me... however, is known about how the drug works at the...ern University researchers now has provided an inv...M bound to copper-loaded metallochaperones. The dr...
Breaking Medicine News(10 mins):Health News:Seniors May Need Help Overcoming Holiday Blues 2Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3
... in revenues through early December , , OWING... ), a leading provider of easy-to-use, clinically ...day announced the company will exceed its previous...on. The Company now expects revenues in excess of ...
... Centers for Faith-Based and Community Initiatives...(USAID) and the Department of Homeland Security (D...ter collaboration in disaster response. The Seni...gether faith-based and community organizations (FB...
...STERIS Isomedix Services for a,one day seminar of...ccess in,medical device sterilization ( http://ww...ng held in San Jose, California on March 11, 2009,...addition to the TechTeam experts from STERIS Isome...
...ealth Blogging on Fire with ,Celebrity Psychings, ...and rock & roll was only the beginning. Today...ed the addition of "Celebrity Psychings," a new bl...essional blogger Alicia Sparks tackles issues head...
...th of stay either, study finds , , TUESDAY...tritional support for intensive care unit (ICU) pa...CU or their risk of death, according to a study by... admission) was important for critically ill patie...
...abetes increases cancer death risk , , TUE...lentil soup and pasta seems to be the way to go if...t a diet of "low-glycemic foods" -- such as beans...-- when it comes to lowering blood sugar and other...
Other Medicine News:Health News:Medifast to Exceed Revenue Guidance for 2008 2Health News:Medifast to Exceed Revenue Guidance for 2008 3Health News:Medifast to Exceed Revenue Guidance for 2008 4Health News:USAID and DHS Host Summit on Partnering with Faith-Based and Community Organizations for Disaster Response 2Health News:STERIS Isomedix Services Offers Medical Device Sterilization Seminar 2Health News:Celebrity Mental Health Musings Take Center Stage as Psych Central Adds New Blog 2Health News:Celebrity Mental Health Musings Take Center Stage as Psych Central Adds New Blog 3Health News:ICU Nutritional Program Failed to Boost Outcomes 2Health News:'Mediterranean'-Style Diet Best for Blood Sugar Control 2Health News:'Mediterranean'-Style Diet Best for Blood Sugar Control 3
(Date:11/25/2009)..., , RANCHO CORDOVA, Calif., Nov. 25 /PRNe...diary of American Pacific Corporation (Nasdaq: AP...ental Responsibility and Sustainability Award at t...d by the California Manufacturers and Technology A...sociation (IEA) and the Chemical Industry Council ...
(Date:11/25/2009)..., , HARBIN, China, Nov. 25 /PRNe...nc. ("China Sky One Medical" or "the Company") (Na...utical company developing and producing,over-the-c...RC"), today,announced that the Company recently pa...l of Pharmaceutical and Biological Products ("ICPB...
(Date:11/25/2009)..., , NEW YORK, Nov. 25 /PRNewswire/ ...search report is available in its catalogue: ,,...tive ,, http://www.reportlinker.com/p0164330...ve.html ,, Rising incidence of breast cancer i...a principal factor influencing growth in the mammo...
Breaking Medicine Technology:AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 3China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Reportlinker Adds Mammography Equipment - A Global Market Perspective 8Howard Dean and Chelsea Green Publishing Utilize iPhone Technology to engage and Mobilize Americans in Healthcare Reform Debate 54615 1Howard Dean and Chelsea Green Publishing Utilize iPhone Technology to engage and Mobilize Americans in Healthcare Reform Debate 54615 2Howard Dean and Chelsea Green Publishing Utilize iPhone Technology to engage and Mobilize Americans in Healthcare Reform Debate 54615 3Howard Dean and Chelsea Green Publishing Utilize iPhone Technology to engage and Mobilize Americans in Healthcare Reform Debate 54615 4Vasogen Receives NASDAQ Notification Related to Minimum Bid Price 13586 1Vasogen Receives NASDAQ Notification Related to Minimum Bid Price 13586 2BioLife Solutions and STEMCELL Technologies Announce Worldwide Distribution Agreement 13583 1BioLife Solutions and STEMCELL Technologies Announce Worldwide Distribution Agreement 13583 2BioLife Solutions and STEMCELL Technologies Announce Worldwide Distribution Agreement 13583 3
...howed Campath May Lead to Overall Survival in Pati...NCISCO, Dec. 9 Bayer HealthCare Pharmaceuticals I...wing that treatment with Campath(R) (alemtuzumab) ...eukemia (CLL) patients who have poor prognostic in...h Annual Meeting of the American Society of Hemato...
...ANCISCO, Dec. 8 Millennium: The Takeda Oncology C...ended follow up of patients from the large, intern... survival improvement for patients with previously...an and prednisone (VcMP). The VELCADE combination ...b-groups, including those with poor prognostic cha...
Other Medicine Technology:Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 2Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 3Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 4Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 5Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 6Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 7Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 8Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 9Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 10Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 2Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 3Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 4Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 5Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 6
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
Medicine Products: